Over-the-counter topical products in dermatology

Area of Science:

• Dermatology
• Pharmacology
• Regulatory Science

Background:

• Over-the-counter (OTC) products are widely used by patients seeking dermatological treatments.
• Dermatologists require comprehensive knowledge of OTC product safety, efficacy, and tolerability for effective patient guidance.
• Understanding the regulatory landscape is crucial for evaluating OTC product claims and recommendations.

Purpose of the Study:

• To discuss the role of the US Food and Drug Administration (FDA) in regulating the safety of OTC dermatological products.
• To review available resources that assist clinicians in understanding the pharmacology and tolerability of OTC products.
• To emphasize the importance of dermatologist familiarity with OTC product profiles.

Main Methods:

• Literature review of FDA regulations pertaining to OTC drug products.
• Survey of educational resources and databases for clinicians regarding OTC product information.
• Analysis of pharmacological data and clinical tolerability studies for common OTC dermatological agents.

Main Results:

• The FDA employs a regulatory framework to ensure the safety and labeling of OTC products.
• Various resources, including online databases and professional guidelines, offer information on OTC product pharmacology and tolerability.
• Key considerations for dermatologists include active ingredients, potential side effects, and evidence supporting efficacy.

Conclusions:

• Dermatologists play a vital role in guiding patients on the safe and effective use of OTC products.
• Familiarity with FDA regulations and accessible resources enhances a clinician's ability to advise on OTC product selection.
• Continuous education on OTC product pharmacology and tolerability is essential for evidence-based dermatological practice.